Here are five takeaways:
1. ReWalk Robotics offers external robotic skeletons for those suffering from spinal cord injuries. The company has a robotic device for both home and clinical rehabilitation use.
2. The offering is for about $6.9 million ordinary shares at $1.05 per share.
3. The gross proceedings equal about $7.2 million.
4. National Securities Corporation is the sole underwriter.
5. The offering will likely close Nov. 21.
More articles on devices:
Zimmer Biomet, K2M, Medicrea & more: 6 device company notes
Invibio invests resources to lower healthcare costs: 5 things to know
Medtronic CEO Omar Ishrak: 5 key points on the future of value-based care for device companies
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
